早产诊断检测套组的全球市场：市场规模、份额、成长分析 - 按测试、最终用户、产业预测（2024-2031）

Global Preterm Birth Diagnostic Test Kits Market Size, Share, Growth Analysis, By Test(Biochemical tests, ultrasound), By End-user(Hospitals, clinics) - Industry Forecast 2024-2031

出版日期: 2024年03月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球早产诊断检测套组市场规模将于2022年达到4.4678亿美元，2023年达到4.7984亿美元，2024-2031年预测期间复合年增长率为7.4%，到2031年预计将达849.44百万美元。

早产发生率上升和早期检测的需求推动了全球早产诊断检测套组市场的发展。这些套件透过检查生物标记和临床指标，有助于快速有效地评估早产的可能性。由于医疗保健专业人员和准妈妈意识的提高以及诊断技术的进步，该市场正在扩大。北美和欧洲由于其强大的医疗基础设施而占据了很大的市场占有率。同时，由于医疗保健支出和意识的不断提高，亚太地区呈现出可喜的成长势头。检测套组开发的持续研究和创新进一步增强了市场前景，旨在减轻全球早产负担。新兴市场趋势越来越重视就地检验，从而能够在更接近患者的情况下快速评估早产风险。

Roche Diagnostics（Switzerland）
Abbott Laboratories（USA）
Siemens Healthineers（Germany）
Thermo Fisher Scientific（USA）
BD（Becton, Dickinson and Company）（USA）
PerkinElmer（USA）
bioMerieux（France）
Hologic, Inc.（USA）
Qiagen（Netherlands）
Danaher Corporation（USA）
Cepheid（USA）
Illumina, Inc.（USA）
Sysmex Corporation（Japan）
Agilent Technologies（USA）
Bio-Rad Laboratories（USA）
GenMark Diagnostics（USA）
Luminex Corporation（USA）
Randox Laboratories（United Kingdom）
NanoString Technologies（USA）
Myriad Genetics（USA）

简介目录

Product Code: SQMIG35A2560

Global Preterm Birth Diagnostic Test Kits Market size was valued at USD 446.78 million in 2022 and is poised to grow from USD 479.84 million in 2023 to USD 849.44 million by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031).

The Global Market for Preterm Birth Diagnostic Test Kits is being propelled by the escalating incidence of preterm births and the imperative for early identification. These kits facilitate prompt and effective evaluation of potential preterm births through the scrutiny of biomarkers and clinical indicators. The market is witnessing expansion driven by heightened awareness among healthcare professionals and expectant mothers, along with advancements in diagnostic technologies. North America and Europe command substantial market shares owing to their robust healthcare infrastructure. Conversely, Asia-Pacific exhibits promising growth due to increasing healthcare expenditure and awareness. Ongoing research and innovation in test kit development are further bolstering market prospects with the aim of alleviating the global burden of preterm births. An emerging trend in the market is the growing emphasis on point-of-care testing, allowing for swift assessments of preterm birth risk in proximity to the patient, which could prove crucial in regions with limited access to advanced healthcare facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preterm Birth Diagnostic Test Kits Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preterm Birth Diagnostic Test Kits Market Segmental Analysis

The global market for preterm birth diagnostic test kits is segmented based on various factors such as test type, end-user, and region. Test types include biochemical tests, ultrasound, genetic screening, and fetal fibronectin tests. End-users comprise hospitals, clinics, diagnostic centers, and research institutions. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Drivers of the Global Preterm Birth Diagnostic Test Kits Market

Preterm birth, occurring prior to 37 weeks of pregnancy, stands as a prominent global health issue, prompting a growing need for precise and dependable diagnostic test kits to detect and forecast preterm labor. This demand is expected to endure, propelled by the escalating rates of preterm births, while healthcare providers and governments emphasize initiatives to decrease such occurrences and enhance maternal and neonatal health outcomes.

Restraints in the Global Preterm Birth Diagnostic Test Kits Market

The medical diagnostic sector operates under stringent regulations to guarantee patient safety and the effectiveness of products. The process of creating and introducing novel diagnostic test kits, particularly those associated with pregnancy and neonatal care, involves thorough testing and approval procedures. The presence of regulatory obstacles can prolong the release of new test kits, affecting their accessibility and widespread adoption in the market.

Market Trends of the Global Preterm Birth Diagnostic Test Kits Market

The market for diagnostic kits aimed at detecting preterm birth is expected to have progressed due to advancements in diagnostic technologies. These improvements likely encompass the creation of more precise and dependable tests, aiding healthcare professionals in predicting the risk of preterm birth with increased accuracy. The enhancements may involve incorporating a variety of biomarkers, genetic testing, proteomics, and other innovative strategies to elevate the sensitivity and specificity of diagnostic tests.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Preterm Birth Diagnostic Test Kits Market by Test

Market Overview
Biochemical tests
ultrasound
genetic screening
and fetal fibronectin tests

Global Preterm Birth Diagnostic Test Kits Market by End-user

Market Overview
Hospitals
clinics
diagnostic centers
and research institutions

Global Preterm Birth Diagnostic Test Kits Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenMark Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments